KEGG   PATHWAY: map07117
Entry
map07117          Drug      Pathway                                
Name
Benzodiazepine family
Class
Pathway map
map07117  Benzodiazepine family
map07117

Compound
C11688  Asperlicin
C15026  L-365260
C15040  GYKI 52466
C15094  GYKI 52895
C15096  GV 150013X
C15104  LY-202769
D00283  Clozapine (JAN/USP/INN)
D00293  Diazepam (JP18/USP/INN)
D00454  Olanzapine (JAN/USP/INN)
D01254  Tofisopam (JP18/INN)
D01858  Panazepide (JAN)
D02693  Devazepide (USAN/INN)
D02694  Tifluadom (INN)
D02696  Talampanel (INN)
D02710  Tarazepide (INN)
D02712  Tibezonium iodide (INN)
Reference
  Authors
David AW, Thomas LL, William OF.
  Title
Foye's Principles of Medicinal Chemistry (5th ed)
  Journal
Lippincott Williams & Wilkins (2002)
Reference
  Authors
Herranz R.
  Title
Cholecystokinin antagonists: pharmacological and therapeutic potential.
  Journal
Med Res Rev 23:559-605 (2003)
DOI:10.1002/med.10042
Reference
  Authors
Zappala M, Grasso S, Micale N, Polimeni S, De Micheli C.
  Title
Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.
  Journal
Mini Rev Med Chem 1:243-53 (2001)
DOI:10.2174/1389557013406783
Reference
  Authors
Solyom S, Tarnawa I.
  Title
Non-competitive AMPA antagonists of 2,3-benzodiazepine type.
  Journal
Curr Pharm Des 8:913-39 (2002)
DOI:10.2174/1381612024607081
Reference
  Authors
Patchett AA.
  Title
2002 Alfred Burger Award Address in Medicinal Chemistry. Natural products and design: interrelated approaches in drug discovery.
  Journal
J Med Chem 45:5609-16 (2002)
DOI:10.1021/jm020424z
Related
pathway
map07213  Dopamine receptor agonists/antagonists
LinkDB

DBGET integrated database retrieval system